Eureka Therapeutics

BiotechnologySeries DEmeryville, USeurekainc.com

Latest round

Series D

Last raised

May 2017

Total raised

$57M

Investors

7

About Eureka Therapeutics

Based in California, US, and founded in 2006, Eureka Therapeutics, Inc. is a clinical-stage biotechnology company. Dr. Cheng Liu is the founder and current President and CEO of the company. In December 2019, Eureka Therapeutics, Inc. The company focuses on creating new T cell treatments for cancer treatment. Its main technology focuses on the discovery and development of potentially safer and more effective T cell treatments for the treatment of solid tumors and hematologic malignancies using its patented ARTEMIS AbTCR T cell receptor platform and E-ALPHA antibody discovery platform.

Who invested in Eureka Therapeutics

7 investors across 4 rounds

See all investors in Eureka Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    May 23, 2017

    Amount

    $33M

    Investors

    Locked

  2. Series C

    Aug 20, 2014

    Amount

    $21M

    Investors

    Locked

  3. Series B

    Oct 28, 2008

    Amount

    $1.7M

    Investors

    Locked

  4. Series A

    Jun 11, 2007

    Amount

    $1.2M

    Investors

    Locked

Questions about Eureka Therapeutics

Who invested in Eureka Therapeutics?

Eureka Therapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Eureka Therapeutics raised?

Eureka Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Eureka Therapeutics last raise money?

Eureka Therapeutics's most recent round on record is a Series D, in May 2017.

What does Eureka Therapeutics do?

Based in California, US, and founded in 2006, Eureka Therapeutics, Inc.

Where is Eureka Therapeutics headquartered?

Eureka Therapeutics is headquartered in Emeryville, US.

Which VCs invest in companies like Eureka Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eureka Therapeutics's stage. Their profiles are linked below.

Raising like Eureka Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.